BURLINGTON, Mass., Sept. 05, 2017 (GLOBE NEWSWIRE) -- LeMaitre Vascular, Inc. (Nasdaq:LMAT) announced today that it will be participating in three investor conferences.

JJ Pellegrino, Chief Financial Officer, is scheduled to present at the R.W. Baird 2017 Healthcare Conference on Thursday, September 7, 2017 at the InterContinental New York Barclay Hotel in New York City.  The Company’s presentation is scheduled to begin at 1:25 PM EDT.

JJ Pellegrino, Chief Financial Officer, will participate in the Morgan Stanley 15^th Annual Global Healthcare Conference on Monday, September 11, 2017 at the Grand Hyatt in New York City.

David Roberts, President, is scheduled to present at the Cantor Fitzgerald Global Healthcare Conference on Tuesday, September 26, 2017 at the InterContinental New York Barclay Hotel in New York City.  The Company’s presentation is scheduled to begin at 2:15 PM EDT.

About LeMaitre Vascular

LeMaitre Vascular is a provider of devices, implants and services for the treatment of peripheral vascular disease, a condition that affects more than 200 million people worldwide. The Company develops, manufactures and markets disposable and implantable vascular devices to address the needs of its core customer, the vascular surgeon. The Company's diversified product portfolio consists of brand name devices used in arteries and veins outside of the heart. Additional information can be found at www.lemaitre.com.

Contact:  
LeMaitre Vascular, Inc.
Investor Relations 
Steven Chehames
+1-781-425-1659
schehames@lemaitre.com

Legal Disclaimer:

EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.